TB study for all ages in Ethiopia
Part of Infections clinical trials.
This trial is testing a new way to find and treat tuberculosis (TB) in communities in Ethiopia. It aims to help people of any age who live in certain areas get better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must live in a study area (called a woreda) in Ethiopia.
- Adults must be 18 or older and agree to be in the study.
- Children 12–17 must agree to join, and a parent or guardian must also agree.
- Children under 12 must have a parent or guardian agree for them.
- You must let the study team contact you by phone or in person if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new ways to diagnose and monitor tuberculosis (TB) in children under 15 who might have TB in their lungs. The goal is to improve how we find and treat TB so children get better faster.
This study is testing new ways to quickly diagnose TB in children under 15. It aims to find better tests that can be used at clinics, especially for kids who may not have obvious symptoms.
This study tests a home-based approach to giving tuberculosis (TB) preventive treatment to children who live with someone recently diagnosed with TB. The goal is to make it easier for families to protect children from getting sick with TB.
This study is testing a new way to diagnose TB in children using simple symptom checklists. It aims to see if these checklists can help doctors find TB earlier and more accurately, especially in children who are very young or have other health problems.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
This study tests ways to help people who live with or are close to someone with tuberculosis get medicine to prevent them from getting sick. It aims to improve how many people start and finish this preventive treatment in Tajikistan and Tanzania.
Hear when a new Reducing Tuberculosis Incidence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.